Help us reach our goal
Thank you for supporting this initiative, your fundraising efforts will make a real difference.
Thank you for your interested in supporting our organisation and medical research into DIPG. Your fundraising efforts will make a real difference.
To make fundraising easier, you can make one-off donation direct to RUN DIPG through this page.
If you are interested in participating in a fundraising event, we’ve created a platform to give you the ability to create your own online fundraising page. In just minutes you can build and customise your page, then start sharing the link with your friends, family and colleagues and asking them to make a donation. Every donation is then recorded on your fundraising page along with a message of support from your donors. So what are you waiting for? Create your own online fundraising page today!
Donate Now
RUN DIPG Donation
LATEST ARTICLES
Together we make all the difference
DIPG cancer researcher Dr Matthew Dun thanks supporters as he races to find a cure
Dr Matt Dun is a University of Newcastle and HMRI biologist leading leukaemia research projects, but has also become driven to use his knowledge and skills to dig deeper into DIPG
Cancer researcher dad fighting for a cure to save his dying daughter
Cancer researcher dad fighting for a cure to save his dying daughter Content
Leukaemia researcher’s desperate crusade to save critically ill daughter
Content by National Nine News - Sydney Bureau - Gabriella Rogers https://twitter.com/9NewsSyd/status/1139215861934411781 An Australian leukaemia
Newcastle and Hunter Rugby Union rivals turn triathlon teammates in name of Matt Dun’s Run DIPG charity
A group of footy rivals team up for a fundraising effort on the triathlon course.
Sunday Tele readers rally behind doctor dad trying to save his daughter from brain cancer
A cancer researcher’s heartbreaking quest to find a treatment for his daughter’s incurable brain cancer has led to an outpouring of donations.
CHANGE A LIFE TODAY
We are a charitable organisation dedicated to improving treatment outcomes for children diagnosed with diffuse intrinsic pontine glioma (DIPG). DIPG is the deadliest form of childhood cancer with an average survival rate of just nine months following diagnosis.